Graha Mitra Asia Tbk. vs Tempo Scan Pacific Tbk. — how do they compare? Graha Mitra Asia Tbk. trades at Rp37 (market cap 217.66B, 2.31M 24h volume), while Tempo Scan Pacific Tbk. trades at Rp2,610 (market cap 11.64T, 278.4K 24h volume). The key difference: Tempo Scan Pacific Tbk. is far larger — about 53.5× Graha Mitra Asia Tbk.'s market cap, and Graha Mitra Asia Tbk. is more actively traded (2.31M versus 278.4K). Which is the better fit depends on your goals.
| RELF | TSPC | |
|---|---|---|
Market Cap | 217.66B | 11.64T |
Volume | 2.31M | 278.4K |
Lot | 23.11K | 2.78K |
Turnover | 84.17M | 723.93M |
Average Price | 36.43 | 2,600.31 |
Value | 84.17M | 723.93M |
Indicative Equilibrium Price | 37 | 2,610 |
Indicative Equilibrium Volume | 1.21K | 74 |
Trailing returns across standard periods
Latest headlines on both assets
PT Graha Mitra Asia Tbk (hereinafter referred to as the "Company") was established based on Deed No. 15 dated 17 April 2018 issued by Notary Susi Aprilina, SH MKn. The Company started its commercial operations in 2018.
Read more on RELF →PT. Tempo Scan Pacific Tbk (the Company) was established in the Republic of Indonesia dated 20 May 1970, under its original name PT Scanchemie within the framework of the Domestic Capital Investment Law No. 6 year 1968, as amended by Law No. 12 year 1970, based on Notarial Deed No. 37 of Ridwan Suselo, S.H. The company is famous for such pharmaceutical products as Bodrex, Hemaviton and Neo-Rheumacyl.
Read more on TSPC →